Zkusit zdarma
Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc.

MACK
Cena:
 
 
Valuace
70
Růst
23
Zdraví
94
preloader

Finanční výsledky Merrimack Pharmaceuticals, Inc. (MACK)

Měna: USD

Ukazatel20232022202120202019
Diluted EPS-0.08-0.11-0.18-0.23-1.59
Gross Profit0-44500000-2.2M
Net Income Attributable to Common Shareholders-1.2M-1.5M-2.5M-3M-21.3M
Operating Profit-2.2M-1.7M-2.5M-2.9M-22.4M
Total Revenues00000